NAT10 mediates ac4C acetylation of BCL9L, SOX4, and AKT1, enhancing their mRNA stability and promoting proliferation, migration, and stemness while inhibiting apoptosis in bladder cancer. Here, NAT10 is linked to urinary bladder cancer.